IFNAR2 and laryngeal carcinoma: Maintaining high expression of IFNAR2 and restoring normal levels of type I interferon can effectively inhibit the proliferation of tumor cells, thereby reducing the risk of laryngeal cancer or improving the treatment effect of laryngeal cancer patients during IFN treatment.